...
机译:JAK2(V617F)通过新型干扰素/砷治疗的肌酚肌肉肿瘤消除涉及PML
Gustave Roussy Inst Natl Sante &
Rech Med INSERM U1287 Villejuif France;
Univ Paris Hop St Louis Inst Rech St Louis IRSL INSERM UMR S1131 Paris France;
Gustave Roussy Inst Natl Sante &
Rech Med INSERM U1287 Villejuif France;
Lab Excellence GR Ex Paris France;
Gustave Roussy Inst Natl Sante &
Rech Med INSERM U1287 Villejuif France;
Univ Paris Hop St Louis Inst Rech St Louis IRSL INSERM UMR S1131 Paris France;
Gustave Roussy Inst Natl Sante &
Rech Med INSERM U1287 Villejuif France;
Univ Paris Hop St Louis Inst Rech St Louis IRSL INSERM UMR S1131 Paris France;
Hop St Louis IRSL INSERM U944 Ctr Natl Rech Sci CNRS UMR7212 Paris France;
Hop St Louis IRSL INSERM U944 Ctr Natl Rech Sci CNRS UMR7212 Paris France;
Gustave Roussy Inst Natl Sante &
Rech Med INSERM U1287 Villejuif France;
Lab Excellence GR Ex Paris France;
Gustave Roussy Inst Natl Sante &
Rech Med INSERM U1287 Villejuif France;
Hop St Louis IRSL INSERM U944 Ctr Natl Rech Sci CNRS UMR7212 Paris France;
机译:jak2 v617f sup>新型干扰素/砷治疗的肌酚瘤肿瘤涉及pml
机译:JAK2 V617F阳性肌酚猕猴桃和ruxolitinib在JAK2 V617F阳性细胞中的HIF-1 Eneasies中的血管生成
机译:JAK2(V617F) - 血管血管利基促进Myeloproiferative肿瘤中的JAK2(V617F)克隆膨胀
机译:与JAK2抑制剂的敏感性和抗性相关的转录和蛋白质组学变化:对BCR-ABL(-)骨髓增生性肿瘤(MPNs)的治疗意义。
机译:来自骨髓增生性肿瘤患者的SH2B3(LNK)突变对野生型JAK2和JAK2 V617F的功能轻微丧失
机译:Cooccurring JAK2 V617F和R1063H突变在野生鳞状肿瘤中增加JAK2信号和中性粒细胞
机译:加强针对骨髓增生性肿瘤的靶向治疗。